FHI Clinical Inc. announced an intent to acquire Triclinium Clinical Development Proprietary Limited from EOH Holdings Limited (JSE:EOH) on December 2, 2021. Deal is expected to close by the end of January. FHI Clinical Inc. completed the acquisition of Triclinium Clinical Development Proprietary Limited from EOH Holdings Limited on December 15, 2021.